Researchers are working on peptides that can withstand the gut and target specific cells. That could open a path to more precise prescription pills.
Recap by typeshit. Post by Facebook on Facebook.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
A short Philstar Life item on PIONEER 8, a trial of oral semaglutide. The material gives only the title, so tap through for the details.
Dr Nadolsky gives his view on what happens when people come off GLP-1 drugs. The clip itself carries the details, and the caption offers little beyond the topic.
A law firm ad offers free case evaluations to Zepbound users who developed NAION, an optic nerve condition, and points to clinical studies on the risk.
Loading…